Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 5

Imatinib Mesylate Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Imatinib Mesylate Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 87 Pages

Report ld: 2332492

  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
Imatinib is a medication used to treat cancer.

The global market for Imatinib Mesylate Drugs was estimated to be worth US$ 341 million in 2023 and is forecast to a readjusted size of US$ 595.2 million by 2030 with a CAGR of 8.5% during the forecast period 2024-2030

Imatinib Mesylate Drugs Market Size

M= millions and B=billions

QYRLogo
For many patients with CML and GIST, Gleevec became a long-term treatment to manage their condition effectively. This sustained demand was driven by the need for ongoing therapy to control cancer progression.

Over time, Gleevec's efficacy in other cancers or its potential use in combination with other treatments may have led to an increase in demand for off-label or investigational uses.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Imatinib Mesylate Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Imatinib Mesylate Drugs by region & country, by Type, and by Application.

The Imatinib Mesylate Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imatinib Mesylate Drugs.

Market Segmentation
  • Report Metric

  • Details

  • Report Title

  • Imatinib Mesylate Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  • Forecasted Market Size in 2030

  • US$ 595.2 million

  • CAGR(2024-2030)

  • 8.5%

  • Market Size Available for Years

  • 2019-2030

  • Global Imatinib Mesylate Drugs Companies Covered

  • Novartis

  • Global Imatinib Mesylate Drugs Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Imatinib Mesylate Drugs Market, Segment by Type

  • 100mg

    400mg

  • Global Imatinib Mesylate Drugs Market, Segment by Application

  • Hospital

    Pharmacy

  • Forecast Units

  • USD million in value

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Imatinib Mesylate Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Imatinib Mesylate Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Imatinib Mesylate Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
 1 Market Overview
1.1 Imatinib Mesylate Drugs Product Introduction
1.2 Global Imatinib Mesylate Drugs Market Size Forecast
1.2.1 Global Imatinib Mesylate Drugs Sales Value (2019-2030)
1.2.2 Global Imatinib Mesylate Drugs Sales Volume (2019-2030)
1.2.3 Global Imatinib Mesylate Drugs Sales Price (2019-2030)
1.3 Imatinib Mesylate Drugs Market Trends & Drivers
1.3.1 Imatinib Mesylate Drugs Industry Trends
1.3.2 Imatinib Mesylate Drugs Market Drivers & Opportunity
1.3.3 Imatinib Mesylate Drugs Market Challenges
1.3.4 Imatinib Mesylate Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

 2 Competitive Analysis by Company
2.1 Global Imatinib Mesylate Drugs Players Revenue Ranking (2023)
2.2 Global Imatinib Mesylate Drugs Revenue by Company (2019-2024)
2.3 Global Imatinib Mesylate Drugs Players Sales Volume Ranking (2023)
2.4 Global Imatinib Mesylate Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Imatinib Mesylate Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Imatinib Mesylate Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Imatinib Mesylate Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Imatinib Mesylate Drugs
2.9 Imatinib Mesylate Drugs Market Competitive Analysis
2.9.1 Imatinib Mesylate Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Imatinib Mesylate Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
3.1 Introduction by Type
3.1.1 100mg
3.1.2 400mg
3.2 Global Imatinib Mesylate Drugs Sales Value by Type
3.2.1 Global Imatinib Mesylate Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Imatinib Mesylate Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Imatinib Mesylate Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Imatinib Mesylate Drugs Sales Volume by Type
3.3.1 Global Imatinib Mesylate Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Imatinib Mesylate Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Imatinib Mesylate Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Imatinib Mesylate Drugs Average Price by Type (2019-2030)

 4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Imatinib Mesylate Drugs Sales Value by Application
4.2.1 Global Imatinib Mesylate Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Imatinib Mesylate Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Imatinib Mesylate Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Imatinib Mesylate Drugs Sales Volume by Application
4.3.1 Global Imatinib Mesylate Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Imatinib Mesylate Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Imatinib Mesylate Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Imatinib Mesylate Drugs Average Price by Application (2019-2030)

 5 Segmentation by Region
5.1 Global Imatinib Mesylate Drugs Sales Value by Region
5.1.1 Global Imatinib Mesylate Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Imatinib Mesylate Drugs Sales Value by Region (2019-2024)
5.1.3 Global Imatinib Mesylate Drugs Sales Value by Region (2025-2030)
5.1.4 Global Imatinib Mesylate Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Imatinib Mesylate Drugs Sales Volume by Region
5.2.1 Global Imatinib Mesylate Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Imatinib Mesylate Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Imatinib Mesylate Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Imatinib Mesylate Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Imatinib Mesylate Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Imatinib Mesylate Drugs Sales Value, 2019-2030
5.4.2 North America Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Imatinib Mesylate Drugs Sales Value, 2019-2030
5.5.2 Europe Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Imatinib Mesylate Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Imatinib Mesylate Drugs Sales Value, 2019-2030
5.7.2 South America Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Imatinib Mesylate Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Imatinib Mesylate Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Imatinib Mesylate Drugs Sales Value
6.2.1 Key Countries/Regions Imatinib Mesylate Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Imatinib Mesylate Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Imatinib Mesylate Drugs Sales Value, 2019-2030
6.3.2 United States Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Imatinib Mesylate Drugs Sales Value, 2019-2030
6.4.2 Europe Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Imatinib Mesylate Drugs Sales Value, 2019-2030
6.5.2 China Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Imatinib Mesylate Drugs Sales Value, 2019-2030
6.6.2 Japan Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Imatinib Mesylate Drugs Sales Value, 2019-2030
6.7.2 South Korea Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Imatinib Mesylate Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Imatinib Mesylate Drugs Sales Value, 2019-2030
6.9.2 India Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
7.1 Novartis
7.1.1 Novartis Company Information
7.1.2 Novartis Introduction and Business Overview
7.1.3 Novartis Imatinib Mesylate Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novartis Imatinib Mesylate Drugs Product Offerings
7.1.5 Novartis Recent Development

 8 Industry Chain Analysis
8.1 Imatinib Mesylate Drugs Industrial Chain
8.2 Imatinib Mesylate Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Imatinib Mesylate Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Imatinib Mesylate Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Imatinib Mesylate Drugs Market Trends
    Table 2. Imatinib Mesylate Drugs Market Drivers & Opportunity
    Table 3. Imatinib Mesylate Drugs Market Challenges
    Table 4. Imatinib Mesylate Drugs Market Restraints
    Table 5. Global Imatinib Mesylate Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Imatinib Mesylate Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Imatinib Mesylate Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Imatinib Mesylate Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Imatinib Mesylate Drugs Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Imatinib Mesylate Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Imatinib Mesylate Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Imatinib Mesylate Drugs
    Table 13. Global Imatinib Mesylate Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Imatinib Mesylate Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Imatinib Mesylate Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Imatinib Mesylate Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Imatinib Mesylate Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Imatinib Mesylate Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Imatinib Mesylate Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Imatinib Mesylate Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Imatinib Mesylate Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Imatinib Mesylate Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Imatinib Mesylate Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Imatinib Mesylate Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Imatinib Mesylate Drugs Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Imatinib Mesylate Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Imatinib Mesylate Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Imatinib Mesylate Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Imatinib Mesylate Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Imatinib Mesylate Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Imatinib Mesylate Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Imatinib Mesylate Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Imatinib Mesylate Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Imatinib Mesylate Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Imatinib Mesylate Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Imatinib Mesylate Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Imatinib Mesylate Drugs Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Imatinib Mesylate Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Imatinib Mesylate Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Imatinib Mesylate Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Imatinib Mesylate Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Imatinib Mesylate Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Imatinib Mesylate Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Imatinib Mesylate Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Imatinib Mesylate Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Imatinib Mesylate Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Imatinib Mesylate Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Imatinib Mesylate Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Imatinib Mesylate Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Imatinib Mesylate Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Imatinib Mesylate Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Imatinib Mesylate Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Imatinib Mesylate Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Imatinib Mesylate Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Novartis Company Information
    Table 58. Novartis Introduction and Business Overview
    Table 59. Novartis Imatinib Mesylate Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Novartis Imatinib Mesylate Drugs Product Offerings
    Table 61. Novartis Recent Development
    Table 62. Key Raw Materials Lists
    Table 63. Raw Materials Key Suppliers Lists
    Table 64. Imatinib Mesylate Drugs Downstream Customers
    Table 65. Imatinib Mesylate Drugs Distributors List
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Imatinib Mesylate Drugs Product Picture
    Figure 2. Global Imatinib Mesylate Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Imatinib Mesylate Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Imatinib Mesylate Drugs Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Imatinib Mesylate Drugs Report Years Considered
    Figure 7. Global Imatinib Mesylate Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Imatinib Mesylate Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Mesylate Drugs Revenue in 2023
    Figure 10. Imatinib Mesylate Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 100mg Picture
    Figure 12. 400mg Picture
    Figure 13. Global Imatinib Mesylate Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Imatinib Mesylate Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Imatinib Mesylate Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Imatinib Mesylate Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Imatinib Mesylate Drugs Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Pharmacy
    Figure 20. Global Imatinib Mesylate Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Imatinib Mesylate Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Imatinib Mesylate Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Imatinib Mesylate Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Imatinib Mesylate Drugs Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Imatinib Mesylate Drugs Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Imatinib Mesylate Drugs Sales Volume (%), (2019-2030)
    Figure 37. United States Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 58. Imatinib Mesylate Drugs Industrial Chain
    Figure 59. Imatinib Mesylate Drugs Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Imatinib is a medication used to treat cancer.

The global market for Imatinib Mesylate Drugs was estimated to be worth US$ 341 million in 2023 and is forecast to a readjusted size of US$ 595.2 million by 2030 with a CAGR of 8.5% during the forecast period 2024-2030
For many patients with CML and GIST, Gleevec became a long-term treatment to manage their condition effectively. This sustained demand was driven by the need for ongoing therapy to control cancer progression.

Over time, Gleevec's efficacy in other cancers or its potential use in combination with other treatments may have led to an increase in demand for off-label or investigational uses.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Imatinib Mesylate Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Imatinib Mesylate Drugs by region & country, by Type, and by Application.

The Imatinib Mesylate Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imatinib Mesylate Drugs.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Imatinib Mesylate Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Imatinib Mesylate Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Imatinib Mesylate Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Imatinib Mesylate Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 87 Pages

Report ld: 2332492

CHOOSE LICENSE TYPE
提示

USD 3950.00

提示

USD 5925.00

提示

USD 7900.00

/uploads/payment/payIcon/masterCard-01.svg/uploads/payment/payIcon/american-express-01.svg/uploads/payment/payIcon/visa-01.svg/uploads/payment/payIcon/diners-club-01.svg/uploads/payment/payIcon/discover-4-01.svg/uploads/payment/payIcon/jcb-01.svg
加入购物车

Add to Cart

立即购买

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

加入购物车

Add to Cart

立即购买

Buy Now